ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
MJC73
|
202 |
84K |
4 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
202
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
MJC73
|
62 |
19K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
62
|
19K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
MJC73
|
62 |
19K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
62
|
19K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
MJC73
|
574 |
191K |
11 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
191K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
MJC73
|
3.4K |
1.1M |
15 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
MJC73
|
60 |
24K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
24K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
10 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
904
|
275K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
13 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
904
|
275K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
10 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
904
|
275K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
13 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
904
|
275K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
3 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
904
|
275K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
$200m MkCap / 30c
|
|
MJC73
|
191 |
66K |
19 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
191
|
66K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
7 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
904
|
275K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
MJC73
|
904 |
275K |
8 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
904
|
275K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
FDA could approve it for the children
|
|
MJC73
|
21 |
6.3K |
8 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
21
|
6.3K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
FDA could approve it for the children
|
|
MJC73
|
21 |
6.3K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
21
|
6.3K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
MJC73
|
1.0K |
389K |
16 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
MJC73
|
1.0K |
389K |
36 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
MJC73
|
1.0K |
389K |
24 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
MJC73
|
1.3K |
544K |
8 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
MJC73
|
1.3K |
544K |
20 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
MJC73
|
1.3K |
544K |
12 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
MJC73
|
1.3K |
544K |
9 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
MJC73
|
1.3K |
544K |
14 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
MJC73
|
3.4K |
1.1M |
24 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
24
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Halt
|
|
MJC73
|
114 |
39K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
114
|
39K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
MJC73
|
362 |
112K |
16 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
362
|
112K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
MJC73
|
9.4K |
2.7M |
11 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
MJC73
|
17K |
6.6M |
5 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
MJC73
|
87 |
45K |
11 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
87
|
45K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
MJC73
|
87 |
45K |
31 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
87
|
45K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
9 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
1.0K
|
383K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
6 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Huge uplift predicted for Mesoblast
|
|
MJC73
|
82 |
29K |
44 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
82
|
29K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
MJC73
|
17K |
6.6M |
4 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
MJC73
|
17K |
6.6M |
6 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
17K
|
6.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
MJC73
|
275 |
110K |
55 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
110K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
MJC73
|
275 |
110K |
21 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
110K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
21 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
15 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
6 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
MJC73
|
17K |
6.6M |
27 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
17K
|
6.6M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
MJC73
|
1.0K |
383K |
5 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
MJC73
|
9.4K |
2.7M |
7 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
MJC73
|
111 |
40K |
22 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
40K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
MJC73
|
111 |
40K |
49 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
40K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
DREAM HF Trial Video
|
|
MJC73
|
99 |
33K |
11 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
99
|
33K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
BLA resubmission timelines
|
|
MJC73
|
12 |
4.1K |
8 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
12
|
4.1K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
MJC73
|
17K |
6.6M |
41 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
17K
|
6.6M
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
MJC73
|
914 |
286K |
13 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
914
|
286K
|
13
|
|